Mabtas 100mg Rituximab Injection

Mabtas 100mg Rituximab Injection is a prescription biologic medication used in the treatment of certain blood cancers and autoimmune disorders, including non-Hodgkin lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, and other conditions involving abnormal B-cell activity. It contains Rituximab, a monoclonal antibody that targets the CD20 protein found on B lymphocytes, helping the immune system identify and destroy these cells. By reducing abnormal or overactive B cells, Mabtas 100mg Rituximab Injection helps control disease progression and improve treatment outcomes. Administered as an intravenous infusion under the supervision of a healthcare professional, it requires regular monitoring to assess treatment response and manage potential infusion-related reactions and other side effects. Patients should use Mabtas 100mg Rituximab Injection only as directed by their healthcare provider.